| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
3 companies
Schwab Andrew J. is a Director, 10% Owner at Camp4 Therapeutics Corp with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 10 sells.
Estimated insider holdings value: $56.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | SKYE Skye Bioscience, Inc. | Director, 10% Owner | Sell | 231,405 | $3.46 | $800,548.50 | -6.7% | -62.0% | - | |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | Director, 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +53.0% | -63.3% | -68.0% | |
| Sep 13, 2024 | SKYE Skye Bioscience, Inc. | - | Sell | 266,337 | $6.57 | $1,750,352.22 | -1.3% | -44.2% | -29.2% |